News
This article was first released to Systematic Income subscribers and free trials on June 12. Welcome to another installment of our Preferreds Market Weekly...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Veris Residential, Inc. (NYSE:VRE) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Taryn Fielder – General Counsel & SecretaryMahbod...
News
Rush Street Interactive, Inc. (NYSE:RSI) Q3 2024 Earnings Call October 30, 2024 6:00 PM ET Company Participants Richard Schwartz – Chief Executive OfficerKyle Sauers...
News
This article was written by Follow For almost a decade, I held research analyst positions in various investment firms, mostly in Toronto. In the...
News
General Dynamics (NYSE:GD) is a proven compounder. This is a stock that you can feel comfortable owning for the long haul, and you can...
News
Vanguard Short-Term Bond Index Fund ETF (NYSEARCA:BSV) tracks the Bloomberg U.S. 1–5 Year Government/Credit Float Adjusted Index. BSV holds both corporate and treasury investment-grade...
News
Strategy Launched by State Street Global Advisors, Inc. and managed by SSGA Funds Management, Inc., the SPDR Dow Jones REIT ETF (NYSEARCA:RWR) invests in...
News
By Fawad Razaqzada The most risk-sensitive currencies like the Australian dollar have outperformed this month (up nearly 6%), owing in part to the surprise...
News
Intro Qualcomm Inc (NASDAQ:QCOM) is a global semiconductor and telecommunications equipment company. The company designs and manufactures semiconductors, software, and related technologies used in...
News
In my initial write-up on Magellan Midstream (NYSE:MMP) in March, I wrote that the stock should give investors a nice high-yield bond-like return. I...
News
What being a value investor means. Value investing to me has 3 steps: 1. Get a sense of the long-term earnings power of a...
News
Investment Summary Following the latest set of investment updates, the case remains largely unchanged for Inogen, Inc. (NASDAQ:NASDAQ:INGN) in my view. Things haven’t improved...
News
This is my second Eiger BioPharmaceuticals (NASDAQ:EIGR) article following 02/2023’s “Eiger BioPharmaceuticals: The Results Are In – The CEO And The CFO Are Out”...
